Prenatal diagnosis is done for the women to prevent the genetic disorders in their babies. During the routine pregnancy period, if the results of blood tests and ultrasound are abnormal then a doctor may ask for the amniocentesis and chorionic villus sampling procedures. The prenatal diagnosis allows to detect the genetic defects and other disorders in the baby and helps parents to take decision of continuing the pregnancy.
Some of the key players of Prenatal Diagnostics Market:
GE Healthcare (General Electric Company), Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffman-La Roche Ltd., Beijing Genomics Institute, Agilent Technologies, Inc., Perkinelmer, Inc., Hologic, Inc., Natera, Inc., Quest Diagnostics, Inc.
Segmentation by Procedure: -
- Ultrasonography
- Chorionic Villus Sampling
- Amniocentesis
- Percutaneous Umbilical Blood Sampling
- Preimplantation Genetic Diagnosis
Segmentation by Product and Services: -
- Instruments
- Consumables
- Services
Segmentation by Application: -
- Chromosome Abnormality
- Genetic Disorders
Segmentation by End User: -
- Hospitals
- Diagnostic
- Laboratories
Comments
Post a Comment